Abstract:This schematic illustrates the multimodality imaging approach to aortic stenosis management, showcasing the interconnected processes of diagnosis, prognosis, and optimal timing for aortic valve replacement, and underscoring the synergy between different diagnostic techniques and their collective impact on clinical decision‐making for patients with moderate aortic stenosis. Created with Biorender.com Abbreviations: AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement; CMR, cardiovascular magnetic resonance; CT, computed tomography; DTI, diffusion tensor imaging; GLS, global longitudinal strain; LGE, late gadolinium enhancement; LV, left ventricle; LVEF, left ventricular ejection fraction. Aortic stenosis (AS) stands as the most common valvular heart disease in developed countries and is characterized by progressive narrowing of the aortic valve orifice resulting in elevated transvalvular flow resistance, left ventricular hypertrophy, and progressive increased risk of heart failure and sudden death. This narrative review explores clinical challenges and evolving perspectives in moderate AS, where discrepancies between aortic valve area and pressure gradient measurements may pose diagnostic and therapeutic quandaries. Transthoracic echocardiography is the first‐line imaging modality for AS evaluation, yet cases of discordance may require the application of ancillary noninvasive diagnostic modalities. This review underscores the importance of accurate grading of AS severity, especially in low‐gradient phenotypes, emphasizing the need for vigilant follow‐up. Current clinical guidelines primarily recommend aortic valve replacement for severe AS, potentially overlooking latent risks in moderate disease stages. The noninvasive multimodality imaging approach—including echocardiography, cardiac magnetic resonance, computed tomography, and nuclear techniques—provides unique insights into adaptive and maladaptive cardiac remodeling in AS and offers a promising avenue to deliver precise indications and exact timing for intervention in moderate AS phenotypes and asymptomatic patients, potentially improving long‐term outcomes. Nevertheless, what we may have gleaned from a large amount of observational data is still insufficient to build a robust framework for clinical decision‐making in moderate AS. Future research will prioritize randomized clinical trials designed to weigh the benefits and risks of preemptive aortic valve replacement in the management of moderate AS, as directed by specific imaging and nonimaging biomarkers.

Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction

Prevalence and prognosis of aortic valve diseases in patients hospitalized with heart failure with mildly reduced ejection fraction

Aortic Stenosis, Heart Failure, and Aortic Valve Replacement

Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long‐Term Registry

Mild aortic valve disease and the diastolic pressure-volume relationship in heart failure with preserved ejection fraction

The Impact of Aortic Valve Replacement on Survival in Patients with Normal Flow Low Gradient Severe Aortic Stenosis: a Propensity-Matched Comparison.

Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis

Early Aortic Valve Replacement vs. Conservative Management in Asymptomatic Severe Aortic Stenosis Patients With Preserved Ejection Fraction: A Meta-Analysis

Prognostic impact of combined non-severe aortic stenosis and mitral regurgitation on clinical outcomes: a single-centre retrospective study

Risk of supranormal left ventricular ejection fraction in patients with aortic stenosis

Definition and Validation of Prognostic Phenotypes in Moderate Aortic Stenosis

Association of cardiac amyloidosis with cardiovascular outcomes after aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis

Arterial Properties and Ventricular-Arterial Interactions in Severe Aortic Stenosis: Impact on Prognosis

Prognostic Impact of Left Ventricular Ejection Fraction in Patients with Moderate Aortic Regurgitation: Potential Implications for Treatment Decision-Making

Moderate aortic stenosis: Navigating the uncharted

Cardiac Damage Staging Predicts Outcomes in Aortic Valve Stenosis After Aortic Valve Replacement: Meta-Analysis

Clinical Outcomes and Predictive Factor Analysis of Mild-to-moderate or Moderate Functional Mitral Regurgitation after Aortic Valve Replacement in Patients with Severe Aortic Stenosis

Abstract 19826: Utility of Stroke Volume Index for Stratification of Patients with Low Gradient Severe Aortic Stenosis and Normal Left Ventricular Ejection Fraction

P195 CARDIOVASCULAR OUTCOMES IN PATIENTS WITH AORTIC STENOSIS AND HYPERTENSION UNDERGOING AORTIC VALVE REPLACEMENT

Natural history of initially asymptomatic severe aortic stenosis: a one-stage meta-analysis

Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis